Katherine Payne, PhD, MSc, DipClinPharm, BPharm, FRPharmS

Prof

  • Manchester Centre for Health Economics Faculty of Biology, Medicine and Health , 4th floor, Jean McFarlane Building The University of Manchester Oxford Road

    M139PL Manchester

If you made any changes in Pure these will be visible here soon.

Personal profile

Overview

Katherine was awarded a personal chair in health economics at The University of Manchester in August 2010. Katherine’s interest in the economics of precision medicine and genomics technologies and services started when she worked as the health economist for the North West Genetics Knowledge Park (Nowgen) between 2003 and 2007. In September 2007, Katherine was awarded a five-year Research Councils UK Academic Fellowship in Health Economics to focus on the evaluation and valuation of genomic technologies including genomic-based diagnostics and pharmacogenetic tests. Katherine was a member of a NICE Technology Appraisal Committee between October 2003 and 2012.

 

Biography

Katherine was awarded a personal Chair in Health Economics at The University of Manchester in August 2010. Katherine is also a registered pharmacist. Between 1990 and 1993, she worked as a hospital pharmacist and has since maintained links with the pharmacy profession to understand the training needs in health economics, in general, and the evaluation of genomic technologies specifically. She has extensive experience working as an academic health economist with different clinical research groups (eg. pharmacy, psychiatry, genetics). In 2007, Katherine joined the newly established Health Sciences - Methodology Group, which allowed her to develop applied and methodological grants. In 2007, she was awarded an RCUK Academic Fellowship to focus on the evaluation and valuation of genomic technologies including genomic-based diagnostics and pharmacogenetic tests. Based in the Manchester Centre for Health Economics, established in August 2012, she is now leading a research group that focuses on the evaluation and valuation of precision medicine and genomic technologies and services.

Research interests

Professor Katherine Payne is an academic health economist with 26-years applied and methodological research experience in the economic evaluation (using RCT and decision-analytic models) and valuation (using discrete choice experiments and contingent valuation) of health care interventions and specifically precision medicine. She developed an interest in genomics when working as the health economist for the North West Genetics Knowledge Park (2003 to 2007) and continues to collaborate closely with colleagues based in the Manchester Centre for Genomic Medicine. This research profile has supported her methodological interest of how to identify, measure and value the benefits of interventions that extend beyond the impact on health.

She has over 140 peer-reviewed publications and had a key role in multi-disciplinary research programmes and projects that, in the last three years, generated a total of over £15.5m for The University of Manchester from MRC, NIHR, Department of Health and Charities (Versus Arthritis and Cancer Research UK). She has been the lead economist on a number of large MRC-funded consortia looking at using targeted approaches (developing prescribing algorithms) for biologics and other medicines (for lupus, psoriasis, rheumatoid arthritis). She is also one of the three Manchester co-applicants on the successful Research Design Service (tender 3) proposal and line manages frontline advisors.

She has a particular interest in the use of economic evidence to inform decision-making in practice and was a member of a NICE Technology Appraisal Committee between October 2003 and 2012. She was a member of a NIHR PGFAR review panel (to March 2021) and has been a member of numerous national funding review panels appraising  projects on the economics of precision medicine (Canada, UK, The Netherlands, France, Switzerland, Singapore, Luxembourg).

Teaching

Joint leader for module on the economics of genomic medicine, Masters in Genomic Medicine, The University of Manchester

 

Memberships of committees and professional bodies

1990 - Member of Royal Pharmaceutical Society

Methodological knowledge

Model-based and prospective economic evaluations

Stated preference methods including discrete choice experiments and contingent valuation

Valuing health and non-health outcomes

Qualifications

  • 2000 - Doctor of Philosophy in Pharmacy Practice(Manchester University)
  • 1994 - Master of Science in Health Economics (York University)
  • 1992 - Diploma in Clinical Pharmacy (West Midlands Region/Keel University)
  • 1989 - Batchelor of Pharmacy (Hons): Class 2 Division 1 (Bath University)

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being
  • SDG 12 - Responsible Consumption and Production

Research Beacons, Institutes and Platforms

  • Digital Futures
  • Christabel Pankhurst Institute

Fingerprint

Dive into the research topics where Katherine Payne is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Network

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or